Voters in 2026 midterm elections decided state health policy ballot measures on abortion rights, marijuana laws, science ...

Following patient deaths, China restricts investigator-initiated biotech trials, leaving rare disease families and US ...

PhRMA spent an estimated $59 million on search advertising over a recent seven-year period to influence how Americans view ...

Novartis has acknowledged seven previously unknown instances in which tumors were found in children who were treated with its ...

Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history.

Democratic doctors won big, MAHA faces an uncertain future, and what the election could mean for Medicare for All.

Three years ago, a trial for a sickle cell gene-editing therapy a decade in the making ended abruptly after the first patient ...

The midterms highlighted the negative sentiment around AI across the U.S. How will those attitudes trickle down to ...

The Democratic flip of the Senate is expected to put two Democrats who support Medicare for All in charge of key committees.

Despite widespread opposition, Medicare will finalize a controversial proposal that will prevent providers, such as hospitals, from using third parties to deliver remote patient monitoring services.

Democrats gained control of both chambers of Congress, and doctors and scientists won key seats. Here are the top health ...

Democratic physicians, nurses, and scientists won dramatic victories across the U.S. on Tuesday, part of the sweeping blue ...